Preparation of Estradiol Submicron Emulsions to Improve Brain Targeting through the Nasal Route in Rats

Author(s):  
Chaoqun Yu ◽  
Xiaomei Wang ◽  
Xing Tang
2019 ◽  
Vol 133 ◽  
pp. 160-166 ◽  
Author(s):  
Lufeng Hong ◽  
Xin Li ◽  
Youmei Bao ◽  
Craig L. Duvall ◽  
Caiyun Zhang ◽  
...  

2012 ◽  
Vol 100 ◽  
pp. 146-154 ◽  
Author(s):  
Hamed A. Salama ◽  
Azza A. Mahmoud ◽  
Amany O. Kamel ◽  
Mayssa Abdel Hady ◽  
Gehanne A.S. Awad
Keyword(s):  

2017 ◽  
Vol 268 ◽  
pp. 364-389 ◽  
Author(s):  
Abdur Rauf Khan ◽  
Mengrui Liu ◽  
Muhammad Wasim Khan ◽  
Guangxi Zhai

2021 ◽  
Vol 22 (8) ◽  
Author(s):  
Hajira Banu Haroon ◽  
Dhrubojyoti Mukherjee ◽  
Jayaraman Anbu ◽  
Banala Venkatesh Teja

Author(s):  
PRAVEEN SIVADASU ◽  
GOWDA D. V. ◽  
SIDDARAMAIAH H. ◽  
HEMALATHA S.

Objective: The present study was an attempt to systemically deliver the most desirable schizophrenia drug, ziprasidone hydrochloride (ZRS) via the intranasal route using nanostructured lipid carrier (NLC) approach. Methods: The desired ZRS loaded NLCs were developed using central composite statistical design and the developed formulation was monitored for improving ZRS bioavailability and their brain targeting efficacy. Results: Pharmacokinetic studies revealed a 10 fold increase (ZRS blood-brain ratio) for NLCs administered through nasal route (in comparison to intravenous route). Similarly, the concentration of ZRS (in the brain) delivered via nasal route exhibits 4 fold increment at all-time points. Conclusion: Therefore, the obtained results suggest a potential nose to brain transport of loaded ZRS by effective bypassing of the Blood-Brain Barrier (BBB).


Author(s):  
Sorakayala Venkata Anusha ◽  
Jonnala Ratna ◽  
Srirama Swarnalatha ◽  
Maruvajala Vidyavathi

Brain targeting has always been challenging due to the presence of physiological barriers by Changing the integrity of these barriers, so as to allow the toxic substances, bacteria and viruses into the brain, Which may severely damage the central nervous system .This problem can be reduced by delivering drugs through the intra nasal route, which by passes the blood brain barrier and reaches into the brain. Nasal route is a non-invasive type, widely used for the local treatment as well as used for systemic therapy as drug delivery directly goes in to systemic circulation. Nasal route provides good absorption of small molecules compared to that of large molecules, absorption of small molecules and large molecules can be increased by absorption promoters. Different drug delivery devices are developed for nasal administration like liquids, semi-solid and solid formulation are consider to deliver the drugs to treat most of  the CNS diseases (i.e. Parkinson’s, Alzheimer’s disease) because it requires specific targeting of drugs to the brain. This review highlighted the challenges, approaches for brain targeting and various drug delivery systems developed with different drugs targeting to brain through nasal administration.


Sign in / Sign up

Export Citation Format

Share Document